NCT02932215View on ClinicalTrials.gov

Use of a Mobile Health Sensor in an Open Label Trial of Lorcaserin for the Treatment of Cannabis Use Disorder

PHASE1CompletedINTERVENTIONAL
Enrollment

17

Participants

Timeline

Start Date

October 31, 2016

Primary Completion Date

January 31, 2019

Study Completion Date

January 17, 2019

Conditions
Cannabis Use Disorder
Interventions
DRUG

lorcaserin

Open label

OTHER

Fitbit Charge HR

This is actually not an intervention- it is a tool to measure activity and sleep; all participants will be receiving one to collect data

Trial Locations (1)

10019

Columbia Substance Treatment and Research Service, New York

All Listed Sponsors
lead

New York State Psychiatric Institute

OTHER

NCT02932215 - Use of a Mobile Health Sensor in an Open Label Trial of Lorcaserin for the Treatment of Cannabis Use Disorder | Biotech Hunter | Biotech Hunter